Company page
Beta Bionics, Inc.
Beta Bionics, Inc. is a public company traded under the ticker BBNX in the American market. The company has a market capitalization of approximately $770.5 million. Beta Bionics focuses on innovative solutions in the healthcare sector, specifically targeting advancements in diabetes management.
- Ticker
- BBNX:NASDAQ
- Asset type
- Stock
- Market cap
- $887.2M
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- NASDAQ
- Currency
- USD